Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Chantal W. M. van Gils"'
1
Evaluation of Patient Registries Supporting Reimbursement Decisions: The Case of Oxaliplatin for Treatment of Stage III Colon Cancer
Autor: Erik Buskens, Chantal W. M. van Gils, Talitha L Feenstra, Leyla Mohseninejad, Carin A. Uyl-de Groot
Publikováno v: Value in Health, 18(1), 84-90. ELSEVIER SCIENCE INC
Value in Health, 18, 84-90. Elsevier Ltd.
Background: Access with evidence development has been established for expensive intramural drugs in The Netherlands. The procedure involves a 4-year period of conditional reimbursement. During this period, additional evidence has to be gathered usual
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e8e4ac6fffc13dda67fd5661616d1d
https://research.rug.nl/en/publications/6eaf3438-b6ad-483a-8815-2229b39e9cbf
Zobrazit plný text záznamu
2
Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence
Autor: Miriam Koopman, Saskia de Groot, Carin A. Uyl-de Groot, Cornelis J. A. Punt, Chantal W. M. van Gils, William K. Redekop
Publikováno v: PharmacoEconomics, 31(8), 703-718. Adis International Ltd
Pharmacoeconomics (Print), 31(8), 703-718. Adis
Previous cost-effectiveness analyses of oxaliplatin have been based on randomised trials whereas current Dutch policy requires evidence from daily practice. The objective of this study was to examine the real-world cost-effectiveness of oxaliplatin p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14dcff4e36eeacb6ecbcd5102c48d4c7
https://pure.amc.nl/en/publications/realworld-costeffectiveness-of-oxaliplatin-in-stage-iii-colon-cancer-a-synthesis-of-clinical-trial-and-daily-practice-evidence(d1fd9625-589e-4dbd-aa8a-d357630f3447).html
Zobrazit plný text záznamu
3
Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands
Autor: Chantal W. M. van Gils, Petronella B. Ottevanger, Linda Mol, Miriam Koopman, Cornelis J. A. Punt
Publikováno v: Acta Oncologica, 52, 950-5
Acta oncologica (Stockholm, Sweden), 52(5), 950-955. Informa Healthcare
Acta Oncologica, 52, 5, pp. 950-5
Item does not contain fulltext Abstract The external validity of trial results is a matter of debate, and no strong evidence is available to support whether a trial may have a positive or a negative effect on the outcome of patients. Methods. We comp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2991d9336032bfcffea02f7644ee81eb
http://hdl.handle.net/2066/118189
Zobrazit plný text záznamu
4
Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands
Autor: Cornelis J. A. Punt, Adri Steenhoek, Margreet G. Franken, Jennifer G. Gaultney, Carin A. Uyl-de Groot, Chantal W. M. van Gils, Miriam Koopman, Gepke O. Delwel, Peter C. Huijgens, William K. Redekop, Wim G. Goettsch
Publikováno v: European Journal of Cancer, 49(1), 8-16. Pergamon
Franken, M G, van Gils, C W M, Gaultney, J G, Delwel, G O, Goettsch, W, Huijgens, P C, Steenhoek, A, Punt, C J A, Koopman, M, Redekop, W K & Uyl-de Groot, C A 2013, ' Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands ', European Journal of Cancer, vol. 49, no. 1, pp. 8-16 . https://doi.org/10.1016/j.ejca.2012.06.010
European Journal of Cancer, 49, 8-16. Elsevier Ltd.
European journal of cancer (Oxford, England, 49(1), 8-16. Elsevier Limited
Objective: To investigate the practical feasibility to develop evidence on drug use and cost-effectiveness in oncology practice. Patients and methods: Feasibility was examined using three Dutch case studies. Each case study investigated the degree of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cfb86fac83e95dfb4c5ebcd2cb8a48e
https://research.vumc.nl/en/publications/cfef1249-7dab-48bf-91b8-a195d8952f50
Zobrazit plný text záznamu
6
Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands
Autor: Chantal W. M. van Gils, William K. Redekop, Cornelis J. A. Punt, Miriam Koopman, Linda Mol, Carin A. Uyl-de Groot
Publikováno v: Acta oncologica (Stockholm, Sweden), 51(1), 57-64. Informa Healthcare
Acta Oncologica, 51, 1, pp. 57-64
Acta Oncologica, 51, 57-64. Informa Healthcare
Acta Oncologica, 51, 57-64
Item does not contain fulltext BACKGROUND: Little is known about how well guidelines about adjuvant chemotherapy in colon cancer are followed in daily practice. We evaluated the current guideline, which is based on the MOSAIC trial, by examining impl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::901da51d2d77e6d2faa84e25b3955cff
https://pubmed.ncbi.nlm.nih.gov/22122695
Zobrazit plný text záznamu
7
The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology
Autor: Leona Hakkaart-van Roijen, Carin A. Uyl-de Groot, Margreet G. Franken, Siok Swan Tan, Chantal W. M. van Gils
Publikováno v: Value in Health, 13(6), 712-719. Elsevier Ltd.
Objectives: Many economic evaluations are conducted in the fields of oncology and hematology, partially owing to the introduction of new expensive drugs in this field. Even though inpatient days, outpatient visits, and daycare treatments are frequent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1045e3ac92589d99ee778632d18a571
https://pubmed.ncbi.nlm.nih.gov/20561330
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje